-
IPO Update: Nkarta Proposes Terms For $150 Million IPO
05 Jul 2020 16:41 GMT
… , CEO and Chairman of OncoMed Pharmaceuticals (OMED) and held similar … liabilities. (Unaudited, interim)
IPO Details NKTX intends to sell … . Listed underwriters of the IPO are Cowen, Evercore ISI, … .S. IPOs with IPO Edge research.
Members of IPO Edge get …
-
Nkarta Begins U.S. IPO Rollout
22 Jun 2020 22:14 GMT
… , CEO and Chairman of OncoMed Pharmaceuticals (OMED) and held similar … liabilities. (Unaudited, interim)
IPO Details Nkarta intends to raise … . Listed bookrunners of the IPO are Cowen, Evercore ISI, … .S. IPOs with IPO Edge research.
Members of IPO Edge get …
-
U.S. IPO Weekly Recap: Lyft And Pinterest Edge Closer To IPO
23 Feb 2019 14:17 GMT
… Nasdaq by merging with OncoMed.
3 Filings During the … insurance industry. IPO Market Snapshot The Renaissance IPO Indices are … Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, … Capital's International IPO ETF (NYSE: IPOS) tracks the index, …
-
IPOs, M&A, and Dividends: Taking A Look At Year-End News Catalysts
14 Dec 2018 20:35 GMT
… of 2018.
Tencent Music’s IPO
Chinese conglomerate Tencent Holding ADR … (OTC: TCEHY) finally held its IPO for its music streaming service … Mereo
As was previously reported, Oncomed Pharmaceuticals Inc. (NASDAQ: OMED) and rare …
-
OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma
05 Dec 2018 21:52 GMT
Xconomy
San Francisco —
OncoMed Pharmaceuticals attracted hundreds of … .
Founded in 2004, OncoMed focused on developing antibody … . Prior to its 2013 IPO, OncoMed had raised $325 million … with pharmaceutical companies.
When OncoMed went public, it raised …
-
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs
15 Oct 2018 07:10 GMT
… data for AGEN2034 (cervical cancer)
Oncomed Pharmaceuticals Inc (NASDAQ: OMED) – Phase … )(after the market close)
IPOs
LogicBio Therapeutics, a pre- … million shares in an IPO, with an estimated price … the ticker symbol SIBN.
IPO Quiet Period Expiry
Elanco …
-
The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More
07 May 2018 00:46 GMT
… )
Ocular Therapeutix Inc (NASDAQ: OCUL)
Oncomed Pharmaceuticals Inc (NASDAQ: OMED)
Prothena Corporation … )
Fibrocell Science Inc (NASDAQ: FCSC)
IPO
Immuno-oncology company Abpro is …
-
Busy Year Ahead For OMED, There's HOPE For GBT, APLS Sinks Below IPO Price
13 Dec 2017 03:33 GMT
The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.
1. OncoMed Pharmaceuticals Inc. (OMED)
Lost 15.52% to close Tuesday's (Dec.12) trading at $3.92.
News: No news
Clinical trials & …
-
OncoMed Pharmaceuticals: Is This $4.50 Busted IPO A Buy?
29 Sep 2017 20:42 GMT
… $150 million, shares of OncoMed Pharmaceuticals (OMED) have lost three … development and commercialization while Oncomed would stand to receive … Celgene and one-third by OncoMed. Profits in the United … time follower to the Busted IPO Forum by clicking here, …
-
Newman Ferrara LLP : Announces Corporate Governance Investigation of OncoMed Pharmaceuticals Inc.
16 May 2017 01:09 GMT
… on behalf of shareholders of OncoMed Pharmaceuticals Inc.
(“OncoMed” or the “Company”) ( … lackluster performance since its 2013
initial public offering, it is clear that the … s direction and leadership.
Current OncoMed stockholders seeking more information on …